Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
Development of Immunostimulatory DNA as a Novel Therapy in Pediatric Acute Lymphoblastic Leukemia
|
Children’s Hospital of Philadelphia / Alix Seif, MD, MPH |
Young Investigator Grants |
2008 |
Pennsylvania |
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements |
University of Cincinnati College of Medicine / Jianjun Chen, PhD |
Innovation Grants |
2013 |
Ohio |
Development of Mithramycin Analogs for Ewing sarcoma |
Van Andel Research Institute / Patrick Grohar, MD/PhD |
Innovation Grants |
2017 |
Michigan |
Development of Nanoparticle-Encapsulated Chemo/Radio-Sensitizers for Intrathecal Delivery |
Yale School of Medicine / Ranjit S. Bindra, MD/PhD & Mark Saltzman, PhD |
Innovation Grants |
2017 |
Connecticut |
Development of New Approaches to Target MAP Kinase Pathway in RAS-driven Rhabdomyosarcoma |
University of Texas Health Science Center at San Antonio / Angelina Vaseva, PhD |
R Accelerated Award Grants |
2023 |
Texas |
Development of Novel Biomarkers for Immunotherapy in Neuroblastoma |
Columbia Institute for Cancer Genetics / Shuobo Boboila, PhD |
Young Investigator Grants |
2017 |
New York |
Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies |
Boston Children’s Hospital / Alan B. Cantor, MD, PhD |
Innovation Grants |
2023 |
Massachusetts |
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan / Carl Koschmann, MD |
Young Investigator Grants |
2014 |
Michigan |
Development of Targeted Leukemia Inhibitors Using Nanoparticle Delivery |
University of Massachusetts Medical School / Lucio Castilla, Ph.D. |
Innovation Grants |
2014 |
Massachusetts |